Clinical and pharmacological group: & nbsp

Proteins and amino acids

Included in the formulation
АТХ:

B.05.B.A.01   Amino acids

Pharmacodynamics:An indispensable amino acid, moderately inhibits the activity of brain enkephalinases.It is a necessary substrate for the synthesis of tyrosine, melanin, dopamine. Participates in the synthesis of thyroxine, the hormone of the thyroid gland, which regulates metabolic processes.

It has a stimulating effect on the central nervous system, reduces dependence on alcohol and opiates, raises the threshold of pain sensitivity, stimulates thyroid function.

Pharmacokinetics:Not described.

Indications:It is used to treat depressive conditions, neurasthenia, vitiligo. It is used in the complex therapy of Parkinson's disease, caffeine, opioid and alcohol dependence, migraine, hyperactivity and attention disorder.

V.F30-F39.F32.9   Depressive episode, unspecified

V.F40-F48.F48.0   Neurasthenia

VI.G00-G09.G09   Consequences of inflammatory diseases of the central nervous system

VI.G20-G26.G20   Parkinson's disease

VI.G20-G26.G21   Secondary Parkinsonism

VI.G40-G47.G43   Migraine

XII.L80-L99.L81   Other disorders of pigmentation

XII.L80-L99.L80   Vitiligo

XVIII.R50-R69.R53   Malaise and fatigue

XXI.Z70-Z76.Z73.0   Overwork

XXI.Z70-Z76.Z73.3   Stress condition, not elsewhere classified

V.F10-F19.F10.3   Mental and behavioral disorders caused by alcohol use - withdrawal symptoms

Contraindications:Phenylketonuria, simultaneous use with MAO inhibitors, individual intolerance.

Carefully:Hypersensitivity, children under 18 years.

Pregnancy and lactation:

Recommendations for FDA - Category C. Contraindicated in pregnancy and lactation.

Dosing and Administration:Inside, 500 mg (1 capsule) 2-3 times a day.

The highest daily dose: 1.5 g.

The highest single dose: 500 mg.

Side effects:

Allergic reactions.

Overdose:Cases of overdose are not described.

Treatment is symptomatic.

Interaction:Contraindicated simultaneous use with nonselective and selective MAO inhibitors types A and B.

Compatible with other antiparkinsonian drugs, antidepressants: imizinom, moclobemide.

Special instructions:In the treatment it is not recommended to drive vehicles and work with moving mechanisms.
Instructions
Up